SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-18-068434
Filing Date
2018-11-14
Accepted
2018-11-14 16:04:04
Documents
73
Period of Report
2018-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q a18-30085_110q.htm 10-Q 1392334
2 EX-31.1 a18-30085_1ex31d1.htm EX-31.1 9606
3 EX-31.2 a18-30085_1ex31d2.htm EX-31.2 9592
4 EX-32.1 a18-30085_1ex32d1.htm EX-32.1 5950
5 EX-32.2 a18-30085_1ex32d2.htm EX-32.2 5916
  Complete submission text file 0001104659-18-068434.txt   6570187

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT repl-20180930.xml EX-101.INS 1461711
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT repl-20180930.xsd EX-101.SCH 52621
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT repl-20180930_cal.xml EX-101.CAL 37885
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT repl-20180930_def.xml EX-101.DEF 174000
10 XBRL TAXONOMY EXTENSION LABELS LINKBASE DOCUMENT repl-20180930_lab.xml EX-101.LAB 482352
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT repl-20180930_pre.xml EX-101.PRE 357639
Mailing Address 18 COMMERCE WAY WOBURN MA 01801
Business Address 18 COMMERCE WAY WOBURN MA 01801 781-995-2443
Replimune Group, Inc. (Filer) CIK: 0001737953 (see all company filings)

IRS No.: 822082553 | State of Incorp.: MA | Fiscal Year End: 0331
Type: 10-Q | Act: 34 | File No.: 001-38596 | Film No.: 181183567
SIC: 2836 Biological Products, (No Diagnostic Substances)
Assistant Director 1